Stakeholder Advisory Boards

To address the Registry's strategic priorities, stakeholders - including industry representatives - are engaged through an advisory forum.

An Industry Advisory Board is currently in place, comprising leading pharmaceutical companies involved in MS and Related Disorders (NMOSD, MOGAD).